Head to Head Review: Bullfrog AI (NASDAQ:BFRG) and Biotricity (OTCMKTS:BTCY)

Biotricity (OTCMKTS:BTCY) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.

Analyst Recommendations

This is a breakdown of recent recommendations for Biotricity and Bullfrog AI, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0	0	0	0	0.00
Bullfrog AI	1	0	0	0	1.00

Earnings & Valuation

This table compares Biotricity and Bullfrog AI”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$13.79 million	0.57	-$8.42 million	($0.17)	-1.65
Bullfrog AI	$60,000.00	134.24	-$6.99 million	($0.69)	-1.02

Bullfrog AI has lower revenue, but higher earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Biotricity has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500.

Insider and Institutional Ownership

3.9% of Biotricity shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 10.1% of Biotricity shares are held by company insiders. Comparatively, 25.2% of Bullfrog AI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Biotricity and Bullfrog AI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biotricity	-30.02%	N/A	-75.50%
Bullfrog AI	N/A	-218.25%	-177.11%

About Biotricity

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

About Bullfrog AI

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.